 Christina Coughlan
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 11 | 2026 | 630 | 2.280 |
Why?
| | Extracellular Vesicles | 9 | 2025 | 171 | 2.030 |
Why?
| | Exosomes | 3 | 2023 | 104 | 0.800 |
Why?
| | Astrocytes | 4 | 2022 | 228 | 0.770 |
Why?
| | Glial Fibrillary Acidic Protein | 3 | 2026 | 122 | 0.750 |
Why?
| | White Matter | 2 | 2023 | 155 | 0.740 |
Why?
| | Gliosis | 2 | 2023 | 30 | 0.710 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2022 | 155 | 0.710 |
Why?
| | Sialyltransferases | 8 | 1999 | 13 | 0.690 |
Why?
| | Amyloid beta-Protein Precursor | 5 | 2022 | 64 | 0.660 |
Why?
| | Ultracentrifugation | 1 | 2020 | 50 | 0.640 |
Why?
| | Healthy Aging | 1 | 2021 | 44 | 0.640 |
Why?
| | Memory, Episodic | 1 | 2021 | 57 | 0.640 |
Why?
| | Amyloid beta-Peptides | 7 | 2026 | 245 | 0.580 |
Why?
| | Neurons | 8 | 2026 | 1652 | 0.560 |
Why?
| | Saccharomyces cerevisiae | 5 | 2022 | 574 | 0.540 |
Why?
| | Proteomics | 4 | 2026 | 1188 | 0.490 |
Why?
| | Peptide Fragments | 3 | 2022 | 696 | 0.460 |
Why?
| | Nanoparticles | 1 | 2020 | 517 | 0.410 |
Why?
| | Cognitive Dysfunction | 3 | 2025 | 468 | 0.400 |
Why?
| | Neurodegenerative Diseases | 2 | 2026 | 143 | 0.400 |
Why?
| | Dexamethasone | 7 | 1999 | 365 | 0.390 |
Why?
| | Biomarkers | 10 | 2026 | 4302 | 0.350 |
Why?
| | Brain Ischemia | 2 | 2025 | 359 | 0.320 |
Why?
| | Herpes Zoster | 3 | 2024 | 319 | 0.310 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2021 | 48 | 0.310 |
Why?
| | Down Syndrome | 4 | 2022 | 525 | 0.310 |
Why?
| | Sialoglycoproteins | 3 | 1997 | 157 | 0.270 |
Why?
| | Protein Folding | 3 | 2005 | 277 | 0.260 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2025 | 161 | 0.250 |
Why?
| | Aging | 4 | 2026 | 1973 | 0.250 |
Why?
| | Interleukin-6 | 3 | 2026 | 779 | 0.240 |
Why?
| | Oligoclonal Bands | 1 | 2026 | 26 | 0.230 |
Why?
| | Herpesvirus 3, Human | 3 | 2024 | 343 | 0.230 |
Why?
| | Neuroblastoma | 3 | 1999 | 174 | 0.230 |
Why?
| | Aged, 80 and over | 9 | 2026 | 8346 | 0.230 |
Why?
| | Plasma | 2 | 2024 | 223 | 0.220 |
Why?
| | Proteome | 2 | 2024 | 513 | 0.220 |
Why?
| | Stroke | 3 | 2023 | 1271 | 0.220 |
Why?
| | Humans | 41 | 2026 | 145763 | 0.220 |
Why?
| | Sodium Bicarbonate | 1 | 2025 | 48 | 0.220 |
Why?
| | Protein Conformation | 2 | 2005 | 938 | 0.220 |
Why?
| | Tetraspanin 28 | 1 | 2024 | 6 | 0.220 |
Why?
| | Intra-Abdominal Fat | 1 | 2025 | 101 | 0.210 |
Why?
| | Chordoma | 1 | 2024 | 17 | 0.210 |
Why?
| | DNA Transposable Elements | 1 | 2025 | 124 | 0.210 |
Why?
| | Acidosis | 1 | 2025 | 105 | 0.210 |
Why?
| | alpha-Synuclein | 1 | 2024 | 46 | 0.210 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2024 | 692 | 0.210 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2025 | 179 | 0.210 |
Why?
| | Amyloidogenic Proteins | 1 | 2024 | 16 | 0.210 |
Why?
| | Aprotinin | 1 | 2004 | 9 | 0.210 |
Why?
| | Mitochondria | 2 | 2025 | 992 | 0.200 |
Why?
| | Vacuoles | 1 | 2004 | 38 | 0.200 |
Why?
| | Osteoblasts | 1 | 2024 | 145 | 0.200 |
Why?
| | Varicella Zoster Virus Infection | 2 | 2024 | 29 | 0.200 |
Why?
| | Glucocorticoids | 3 | 1999 | 532 | 0.200 |
Why?
| | Carcinogenesis | 1 | 2025 | 228 | 0.200 |
Why?
| | Recombinant Proteins | 2 | 2007 | 1368 | 0.200 |
Why?
| | Central Nervous System | 1 | 2026 | 282 | 0.200 |
Why?
| | Animals | 24 | 2025 | 38097 | 0.200 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 735 | 0.190 |
Why?
| | Bleomycin | 1 | 2024 | 255 | 0.190 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 220 | 0.190 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 290 | 0.190 |
Why?
| | Colon | 1 | 2025 | 309 | 0.180 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 100 | 0.180 |
Why?
| | tau Proteins | 2 | 2026 | 105 | 0.180 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 71 | 0.180 |
Why?
| | Apolipoprotein E4 | 1 | 2022 | 42 | 0.180 |
Why?
| | Disease | 1 | 2003 | 96 | 0.180 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2025 | 293 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 4 | 2011 | 473 | 0.180 |
Why?
| | Fatty Acids | 1 | 2025 | 457 | 0.170 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2024 | 638 | 0.170 |
Why?
| | Cognition | 3 | 2025 | 1271 | 0.170 |
Why?
| | Immunoglobulin G | 1 | 2026 | 892 | 0.170 |
Why?
| | Obesity | 2 | 2025 | 3118 | 0.170 |
Why?
| | Endoplasmic Reticulum | 1 | 2004 | 264 | 0.170 |
Why?
| | Aged | 13 | 2026 | 26215 | 0.170 |
Why?
| | Retinal Drusen | 1 | 2021 | 31 | 0.170 |
Why?
| | Virion | 1 | 2022 | 108 | 0.170 |
Why?
| | Peptides | 2 | 2024 | 998 | 0.170 |
Why?
| | Retinal Pigment Epithelium | 1 | 2021 | 79 | 0.170 |
Why?
| | Arteritis | 1 | 2021 | 23 | 0.170 |
Why?
| | Aldosterone | 4 | 1999 | 42 | 0.170 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2022 | 78 | 0.160 |
Why?
| | Chemical Precipitation | 1 | 2020 | 39 | 0.160 |
Why?
| | Cell Polarity | 1 | 2021 | 137 | 0.160 |
Why?
| | Health Status | 1 | 2026 | 835 | 0.160 |
Why?
| | Myelitis | 1 | 2022 | 107 | 0.160 |
Why?
| | Neurofilament Proteins | 3 | 2026 | 79 | 0.160 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2021 | 154 | 0.160 |
Why?
| | Adipose Tissue | 1 | 2025 | 645 | 0.160 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 693 | 0.160 |
Why?
| | Enterovirus D, Human | 1 | 2022 | 87 | 0.160 |
Why?
| | Stem Cells | 1 | 2025 | 630 | 0.160 |
Why?
| | Multiple Sclerosis | 1 | 2026 | 489 | 0.160 |
Why?
| | Amyloid | 1 | 2021 | 96 | 0.160 |
Why?
| | Cell Movement | 1 | 2024 | 961 | 0.150 |
Why?
| | Middle Aged | 13 | 2026 | 36302 | 0.150 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 48 | 0.150 |
Why?
| | Neuromuscular Diseases | 1 | 2022 | 145 | 0.150 |
Why?
| | Inflammation | 3 | 2026 | 2883 | 0.150 |
Why?
| | Chemokine CCL2 | 1 | 2000 | 112 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 3 | 1999 | 484 | 0.150 |
Why?
| | Macular Degeneration | 1 | 2021 | 191 | 0.150 |
Why?
| | Enterovirus Infections | 1 | 2022 | 173 | 0.150 |
Why?
| | Male | 18 | 2026 | 73003 | 0.140 |
Why?
| | Wnt-5a Protein | 1 | 2018 | 25 | 0.140 |
Why?
| | Fibroblasts | 1 | 2024 | 1027 | 0.140 |
Why?
| | Signal Transduction | 4 | 2021 | 5223 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 668 | 0.140 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3551 | 0.140 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2017 | 18 | 0.130 |
Why?
| | Melanoma | 1 | 2024 | 761 | 0.130 |
Why?
| | Female | 17 | 2026 | 79035 | 0.130 |
Why?
| | Kidney | 2 | 2015 | 1496 | 0.130 |
Why?
| | Cell Communication | 2 | 2000 | 327 | 0.130 |
Why?
| | N-Acetylneuraminic Acid | 2 | 1999 | 16 | 0.130 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 5 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2025 | 868 | 0.130 |
Why?
| | Aneuploidy | 1 | 2017 | 91 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2025 | 928 | 0.130 |
Why?
| | Tumor Cells, Cultured | 5 | 2000 | 887 | 0.120 |
Why?
| | Glycosylation | 4 | 2026 | 173 | 0.120 |
Why?
| | Trisomy | 1 | 2017 | 78 | 0.120 |
Why?
| | Brain Chemistry | 1 | 1996 | 120 | 0.120 |
Why?
| | Isoenzymes | 1 | 1996 | 295 | 0.110 |
Why?
| | Proteins | 1 | 2021 | 1023 | 0.110 |
Why?
| | Models, Biological | 1 | 2003 | 1764 | 0.110 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2025 | 46 | 0.110 |
Why?
| | Rats | 8 | 2025 | 5585 | 0.110 |
Why?
| | Carcinoma, Hepatocellular | 2 | 1997 | 373 | 0.110 |
Why?
| | Apoptosis | 3 | 2025 | 2443 | 0.110 |
Why?
| | Cystic Fibrosis | 1 | 2005 | 1163 | 0.110 |
Why?
| | Adult | 8 | 2026 | 40872 | 0.100 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2883 | 0.100 |
Why?
| | Brain | 4 | 2023 | 2969 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4568 | 0.100 |
Why?
| | Mice | 10 | 2025 | 18355 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2021 | 1359 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 263 | 0.100 |
Why?
| | Membrane Proteins | 3 | 2024 | 1166 | 0.090 |
Why?
| | Enzyme Induction | 3 | 1997 | 88 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 1996 | 592 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2015 | 2131 | 0.090 |
Why?
| | Transcription Factor AP-2 | 1 | 2011 | 82 | 0.090 |
Why?
| | Glioma | 1 | 1995 | 429 | 0.080 |
Why?
| | Parkinson Disease | 1 | 2017 | 601 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 631 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5992 | 0.080 |
Why?
| | Membrane Transport Proteins | 1 | 2011 | 154 | 0.080 |
Why?
| | Adrenalectomy | 4 | 1999 | 68 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2021 | 4151 | 0.080 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2026 | 3937 | 0.070 |
Why?
| | Receptors, Nicotinic | 1 | 2011 | 327 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1197 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2602 | 0.070 |
Why?
| | Palliative Care | 1 | 2017 | 1022 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 826 | 0.070 |
Why?
| | Caregivers | 1 | 2017 | 1074 | 0.070 |
Why?
| | DNA-Binding Proteins | 2 | 2025 | 1482 | 0.070 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2011 | 414 | 0.060 |
Why?
| | Schizophrenia | 1 | 2011 | 464 | 0.060 |
Why?
| | Transcription Factors | 2 | 2025 | 1736 | 0.060 |
Why?
| | Drug Stability | 1 | 2007 | 169 | 0.060 |
Why?
| | Liver | 1 | 1996 | 1899 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 505 | 0.060 |
Why?
| | Chemokine CXCL5 | 1 | 2026 | 19 | 0.060 |
Why?
| | Chemokine CXCL9 | 1 | 2026 | 38 | 0.060 |
Why?
| | Golgi Apparatus | 2 | 2004 | 99 | 0.060 |
Why?
| | Polysaccharides | 2 | 2004 | 86 | 0.060 |
Why?
| | Mutation | 4 | 2017 | 4090 | 0.060 |
Why?
| | Protein Aggregates | 1 | 2026 | 85 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
| | Middle Cerebral Artery | 1 | 2025 | 56 | 0.060 |
Why?
| | Cytokines | 2 | 2024 | 2069 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2024 | 376 | 0.060 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2025 | 48 | 0.060 |
Why?
| | DNA Methylation | 2 | 2025 | 690 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2023 | 3634 | 0.050 |
Why?
| | Kinetics | 2 | 1998 | 1568 | 0.050 |
Why?
| | Calnexin | 1 | 2004 | 3 | 0.050 |
Why?
| | Centrifugation, Density Gradient | 1 | 2004 | 36 | 0.050 |
Why?
| | Cycloheximide | 1 | 2004 | 42 | 0.050 |
Why?
| | Concanavalin A | 1 | 2004 | 72 | 0.050 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2004 | 45 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2004 | 90 | 0.050 |
Why?
| | Mass Spectrometry | 1 | 2007 | 731 | 0.050 |
Why?
| | Cell Death | 1 | 2025 | 382 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 65 | 0.050 |
Why?
| | Fluorescent Dyes | 1 | 2025 | 334 | 0.050 |
Why?
| | Base Sequence | 1 | 2007 | 2171 | 0.050 |
Why?
| | Virus Activation | 1 | 2024 | 94 | 0.050 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2004 | 48 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 78 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 340 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 25 | 0.050 |
Why?
| | Disulfides | 1 | 2004 | 94 | 0.050 |
Why?
| | Time Factors | 2 | 2025 | 7133 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2025 | 266 | 0.050 |
Why?
| | Sucrose | 1 | 2004 | 114 | 0.050 |
Why?
| | Hippocampus | 2 | 2022 | 973 | 0.050 |
Why?
| | Chemokines, CXC | 1 | 2003 | 68 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2004 | 143 | 0.050 |
Why?
| | Carbohydrate Sequence | 3 | 1999 | 29 | 0.050 |
Why?
| | Neurites | 1 | 2023 | 50 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2023 | 78 | 0.050 |
Why?
| | beta Catenin | 1 | 2025 | 254 | 0.050 |
Why?
| | Plasmids | 1 | 2004 | 373 | 0.050 |
Why?
| | Interferon-gamma | 1 | 2026 | 784 | 0.050 |
Why?
| | Imipramine | 1 | 2022 | 11 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2026 | 5922 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 89 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 212 | 0.050 |
Why?
| | Chemokines | 1 | 2003 | 217 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2601 | 0.050 |
Why?
| | Densitometry | 1 | 2022 | 36 | 0.040 |
Why?
| | Retinal Ganglion Cells | 1 | 2003 | 121 | 0.040 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 73 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 156 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2024 | 474 | 0.040 |
Why?
| | Virus Internalization | 1 | 2022 | 65 | 0.040 |
Why?
| | Viral Proteins | 1 | 2024 | 350 | 0.040 |
Why?
| | Polymerization | 1 | 2022 | 127 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 855 | 0.040 |
Why?
| | Catalysis | 1 | 2022 | 305 | 0.040 |
Why?
| | Cattle | 1 | 2004 | 946 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1068 | 0.040 |
Why?
| | Chromatin | 1 | 2025 | 553 | 0.040 |
Why?
| | Lectins | 2 | 1998 | 44 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2025 | 3130 | 0.040 |
Why?
| | Interneurons | 1 | 2022 | 125 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2000 | 22 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2023 | 248 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 300 | 0.040 |
Why?
| | Immune System | 1 | 2022 | 180 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2021 | 273 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 317 | 0.040 |
Why?
| | Retina | 1 | 2003 | 329 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 2000 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2064 | 0.040 |
Why?
| | Teratocarcinoma | 1 | 2000 | 2 | 0.040 |
Why?
| | Phagocytosis | 1 | 2021 | 296 | 0.040 |
Why?
| | Receptors, Dopamine D2 | 1 | 2000 | 93 | 0.040 |
Why?
| | Intracellular Space | 1 | 2020 | 64 | 0.040 |
Why?
| | Organoids | 1 | 2021 | 144 | 0.040 |
Why?
| | Acyclovir | 1 | 2020 | 98 | 0.040 |
Why?
| | Extracellular Space | 1 | 2020 | 117 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1897 | 0.040 |
Why?
| | Phytohemagglutinins | 1 | 1999 | 29 | 0.040 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 98 | 0.040 |
Why?
| | Cell Line | 2 | 2022 | 2823 | 0.040 |
Why?
| | Cerebral Palsy | 1 | 2021 | 138 | 0.040 |
Why?
| | Thrombosis | 1 | 2023 | 400 | 0.040 |
Why?
| | DNA, Viral | 1 | 2021 | 356 | 0.040 |
Why?
| | Nicotine | 1 | 2021 | 331 | 0.040 |
Why?
| | Genotype | 1 | 2004 | 1857 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 611 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 273 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1329 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 231 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1450 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2011 | 2805 | 0.030 |
Why?
| | MicroRNAs | 1 | 2024 | 686 | 0.030 |
Why?
| | Asialoglycoproteins | 1 | 1997 | 2 | 0.030 |
Why?
| | Fetuins | 1 | 1997 | 3 | 0.030 |
Why?
| | Cytidine Monophosphate N-Acetylneuraminic Acid | 1 | 1997 | 3 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2000 | 245 | 0.030 |
Why?
| | Nervous System | 1 | 1998 | 69 | 0.030 |
Why?
| | Protein Binding | 1 | 2004 | 2240 | 0.030 |
Why?
| | alpha-Fetoproteins | 1 | 1997 | 42 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 199 | 0.030 |
Why?
| | Gene Dosage | 1 | 2017 | 145 | 0.030 |
Why?
| | Tretinoin | 1 | 1998 | 125 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 43 | 0.030 |
Why?
| | Heterozygote | 1 | 2017 | 314 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 1996 | 15 | 0.030 |
Why?
| | Glycoproteins | 1 | 1998 | 354 | 0.030 |
Why?
| | Oligosaccharides | 1 | 1996 | 60 | 0.030 |
Why?
| | Parietal Lobe | 1 | 1996 | 61 | 0.030 |
Why?
| | Glutathione Reductase | 1 | 2015 | 24 | 0.030 |
Why?
| | Peroxiredoxins | 1 | 2015 | 25 | 0.030 |
Why?
| | Substrate Specificity | 1 | 1996 | 387 | 0.030 |
Why?
| | Brain Stem | 1 | 1996 | 98 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2015 | 92 | 0.030 |
Why?
| | Fetus | 1 | 2000 | 804 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 1998 | 286 | 0.030 |
Why?
| | Adolescent | 2 | 2025 | 22573 | 0.030 |
Why?
| | Acetylation | 1 | 2015 | 259 | 0.030 |
Why?
| | Aldehydes | 1 | 2015 | 140 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 209 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 572 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 769 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2017 | 554 | 0.030 |
Why?
| | Cerebellum | 1 | 1996 | 224 | 0.030 |
Why?
| | Glutathione | 1 | 2015 | 370 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 308 | 0.020 |
Why?
| | Cell Differentiation | 2 | 1998 | 2050 | 0.020 |
Why?
| | Risk Assessment | 1 | 2023 | 3752 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2017 | 916 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2191 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 1995 | 442 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 529 | 0.020 |
Why?
| | SEC Translocation Channels | 1 | 2011 | 9 | 0.020 |
Why?
| | Risk Factors | 1 | 2026 | 10917 | 0.020 |
Why?
| | Amino Acids | 1 | 2015 | 519 | 0.020 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2011 | 94 | 0.020 |
Why?
| | Lung | 1 | 2024 | 4116 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2011 | 376 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 176 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 192 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11868 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2011 | 335 | 0.020 |
Why?
| | HeLa Cells | 1 | 2011 | 632 | 0.020 |
Why?
| | Protein Transport | 1 | 2011 | 442 | 0.020 |
Why?
| | Qualitative Research | 1 | 2017 | 1683 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 638 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14251 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 11793 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1247 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2219 | 0.020 |
Why?
| | Child | 1 | 2025 | 22739 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1454 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17325 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2003 | 120 | 0.010 |
Why?
| | Chick Embryo | 1 | 2003 | 132 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2003 | 74 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2003 | 83 | 0.010 |
Why?
| | Chemokine CXCL12 | 1 | 2003 | 86 | 0.010 |
Why?
| | Nerve Growth Factors | 1 | 2003 | 79 | 0.010 |
Why?
| | Receptors, CXCR4 | 1 | 2003 | 91 | 0.010 |
Why?
| | Infant | 1 | 2017 | 10090 | 0.010 |
Why?
| | Cell Count | 1 | 2003 | 319 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2003 | 208 | 0.010 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 125 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 288 | 0.010 |
Why?
| | Apelin Receptors | 1 | 2000 | 4 | 0.010 |
Why?
| | Dopamine D2 Receptor Antagonists | 1 | 2000 | 5 | 0.010 |
Why?
| | Apelin | 1 | 2000 | 10 | 0.010 |
Why?
| | Adipokines | 1 | 2000 | 57 | 0.010 |
Why?
| | Receptors, Virus | 1 | 2000 | 95 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2000 | 93 | 0.010 |
Why?
| | Cell Survival | 1 | 2003 | 1103 | 0.010 |
Why?
| | Primates | 1 | 2000 | 133 | 0.010 |
Why?
| | Swainsonine | 1 | 1999 | 1 | 0.010 |
Why?
| | 1-Deoxynojirimycin | 1 | 1999 | 1 | 0.010 |
Why?
| | Mannosidases | 1 | 1999 | 3 | 0.010 |
Why?
| | Neuraminidase | 1 | 1999 | 25 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 335 | 0.010 |
Why?
| | Phosphorylation | 1 | 2003 | 1708 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 927 | 0.010 |
Why?
| | Biological Transport | 1 | 1999 | 424 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2000 | 574 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2000 | 1261 | 0.010 |
Why?
| | Solubility | 1 | 1998 | 240 | 0.010 |
Why?
| | Blotting, Western | 1 | 1999 | 1184 | 0.010 |
Why?
| | Pituitary Neoplasms | 1 | 1999 | 190 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 729 | 0.010 |
Why?
| | HIV-1 | 1 | 2000 | 908 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2000 | 1505 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2000 | 1997 | 0.010 |
Why?
|
|
Coughlan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|